Description

I help clients solve complex business problems and move from strategy to execution with clarity, pace, and measurable results. What I bring to the table is a combination of structured consulting rigor, strong commercial judgment, and hands-on delivery leadership—so I can not only shape the right direction, but also make sure it gets implemented effectively.

What makes me stand out is my ability to simplify ambiguity, align cross-functional teams, and turn analysis into action. I add value by creating focus where there is noise, building practical plans that people can execute, and maintaining momentum through strong governance, stakeholder management, and clear communication. I’m especially effective in situations that require both big-picture thinking and operational follow-through.

I typically lead and deliver projects such as strategic planning and growth initiatives, transformation and performance improvement programs, operating model design, PMO and governance setup, market and competitive assessments, due diligence and integration support, KPI/dashboard development, and executive-ready business cases and decision materials. My deliverables often include strategy roadmaps, implementation plans, performance frameworks, risk and issue registers, steering committee packs, and clear recommendations that support confident leadership decisions.

Languages

English
Native or bilingual
Urdu
Native or bilingual

Workplace preferences

Can work on-site

London (up to 50km)

ALVAREZ & MARSAL
Associate
CONSULTING AND AUDITS
December 2020 - February 2025 (4 years and 2 months)
London, UK
● Built a plant capacity utilisation and revenue growth model for a UK pharma manufacturer, identifying a £100 million revenue uplift opportunity as part of operational due diligence for investors
● Collaborated with supply chain leadership at a leading Spanish pharmaceutical company with revenues of c.€7 billion and external logistics providers to develop an international freight RFP, analyse financial impact of quotations and present findings to client's senior leadership team; resulted in €6 million in annualised savings and reduced lead times
● Led an inventory and headcount analysis during a manufacturing operations assessment at the Japan plant of a global power tools manufacturer with revenues of c.$15 billion by analysing financial, inventory and headcount data in close collaboration with the Japanese client team, identified savings of c.$7 million in the former and c.$2 million in the latter
● Assessed operational and financial performance across c.90 clinics at a leading UK-based clinic business and assisted with interviewing clinic leadership teams across 3 regions, identifying 3 candidates for turnaround and 7 for closure; assisted in development and implementation of turnaround plans across 12 workstreams
● Designed and implemented performance dashboard at a UK-based clinic business to monitor KPIs, delivering insights to C-suite and driving data-informed decision-making
● Costed a comprehensive transitional services agreement for a UK-based CDMO across IT, HR, Finance, Quality and Procurement and supported senior leadership on the buy-side team with negotiations during the acquisition of an Irish pharmaceutical manufacturing plant, ensuring business continuity during the acquisition period
● Led vendor due diligence for the Beijing plant of a $2 billion global pharmaceutical company, coordinating with the local plant leadership and global HQ in Cambridge, assessing operational independence for prospective buyers
●
Business analysis KPIs and Metric Definition and Monitoring Project Management Change and Transformation Management
CERA CARE
Commercial Manager
June 2020 - December 2020 (6 months)
London, UK
• ● Drove UK market expansion by developing a demographic analysis and competitive screening for potential acquisition targets; identified 2 acquisition targets worth £5.4 million, unlocking £18 million in revenue synergies
• ● Executed commercial due diligence by assessing Cera's employee needs for an ongoing multi-million pound acquisition, identifying cost savings of approximately £250,000
• ● Developed investor-ready DCF valuation model and scenario forecasts to support Series B fundraising, enhancing investor engagement and deal momentum
Business analysis Communication
AUROBINDO PHARMA
Business and Operations Analyst
September 2016 - June 2018 (1 year and 9 months)
London, UK
• ● Evaluated in-licensing opportunities, identifying €5 million incremental sales revenue through targeted product additions